awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52099813-2E979927-6A41-4D6F-914F-740EE067432C
Q52099813-2E979927-6A41-4D6F-914F-740EE067432C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52099813-2E979927-6A41-4D6F-914F-740EE067432C
Preclinical Analgesic and Safety Evaluation of the GalR2-preferring Analog, NAX 810-2.
P2860
Q52099813-2E979927-6A41-4D6F-914F-740EE067432C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52099813-2E979927-6A41-4D6F-914F-740EE067432C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b0a82218b864d09cf23e30af526a2106c6b9da88
P2860
Introduction of lipidization-cationization motifs affords systemically bioavailable neuropeptide Y and neurotensin analogs with anticonvulsant activities.